Home / Insights / Anti-counterfeiting technology - A must have for pharmaceutical organizations

insights-espresso-icon article

Anti-counterfeiting technology - A must have for pharmaceutical organizations

Espresso-live Speakers
by Sarabjeet Singh Sharad
23 April 2015

International free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs worldwide. Almost 10 % of medicines representing close to 75billion dollars globally are said to be illegal. Around 1% of products in the legal pharmaceutical supply chain in the developed world are estimated to be counterfeit, while this figure is 10-15% in emerging markets and 30% in developing countries. Drug counterfeiting is expected to increase in the future as pharma is expanding to emerging and developing market where this demand for pharmaceuticals products will increase the supply of counterfeit drugs in future. Technological protection is seen to be the best way to avoid this problem, which will strengthen the security of pharmaceutical supply chain through innovative technologies like overt, covert, forensic and track & trace. This article will emphasize on the use of such technologies in pharma.

Linkedin Twitter Facebook
Leave a comment

Please enter a valid name

Post your comment

Please select captcha


Get more stories like this

Subscirbe for more news,updates and insights from Beroe

Get Ahead with AI-Enabled Market Insights Schedule a Demo Now

Schedule a Demo Now